Overview
TB-500 is a research peptide corresponding to the active region of thymosin beta-4, a 43-amino-acid actin-binding protein involved in cytoskeletal dynamics, cell migration, and angiogenesis. The commonly studied fragment LKKTETQ represents the core motif responsible for actin sequestration and related regenerative phenotypes in cell culture research. TB-500 enables investigation of G-actin buffering, lamellipodia formation, and endothelial sprouting independent of full-length thymosin beta-4 expression levels. In regenerative research laboratories, TB-500 serves alongside BPC-157 and other cytoskeletal modulators to dissect actin remodeling contributions to tissue repair models in controlled preclinical experiments without implying clinical wound therapy. Supplied at ≥98% purity (C212H350N56O78S; 4963.5 g/mol), this material supports controlled laboratory investigation under research-use-only conditions.